Department of Digestive and Endocrine Surgery, University Hospital of Reims, Reims, France; University of Champagne Ardenne, France.
Department of Digestive and Endocrine Surgery, University Hospital of Reims, Reims, France; University of Champagne Ardenne, France.
Eur J Surg Oncol. 2022 Feb;48(2):455-461. doi: 10.1016/j.ejso.2021.09.015. Epub 2021 Sep 21.
Early detection of postoperative infectious complications (IC) is crucial after Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). The aim of this study was to evaluate the predictive role of early postoperative inflammatory biomarkers level for the detection of postoperative IC.
a retrospective study was performed including 199 patients treated with complete CRS/HIPEC for PC from various primary origins from September 2012 to January 2021. Patients were monitored by a routine measurement of inflammatory biomarkers (CRP, leukocytes, neutrophils, lymphocytes, neutrophile-to-lymphocyte ratio and platelets-to-lymphocyte ratio). Inflammatory biomarkers were compared between patients with vs without IC.
IC occurred for 68 patients (34.2%). CRP values were significantly higher in patients with IC on POD 3, 5 and 7 (CRP = 166 mg/L [128-244], 155 mg/L [102-222] and 207 mg/L [135-259], respectively). The CRP on POD7, with a cut-off value of 100 mg/L, was an excellent predictor of postoperative IC (AUC = 90.1%). The CRP on POD 5, with a cut-off value of 90 mg/L, was a good predictor of postoperative IC (AUC = 83.2%). NLR values were significantly higher in patients with IC on POD 3, 5 and 7. NLR on POD 5 and 7 higher than 9.7 and 6.3, respectively, were fair predictors (AUC = 70.8 and 79.6, respectively).
CRP levels between POD3 and 7 are the best predictors of postoperative IC after CRS/HIPEC. The presence of postoperative IC should be suspected in patients with CRP higher than 140 mg/L, 90 mg/L or 100 mg/L on PODs 3, 5 or 7.
细胞减灭术联合腹腔热灌注化疗(CRS/HIPEC)后,早期发现术后感染性并发症(IC)至关重要。本研究旨在评估术后早期炎症生物标志物水平对术后 IC 检测的预测作用。
回顾性研究纳入了 2012 年 9 月至 2021 年 1 月期间因各种原发部位 PC 接受完全 CRS/HIPEC 治疗的 199 例患者。通过常规测量炎症生物标志物(CRP、白细胞、中性粒细胞、淋巴细胞、中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值)对患者进行监测。比较了有和无 IC 患者之间的炎症生物标志物。
68 例患者(34.2%)发生 IC。IC 患者术后第 3、5、7 天 CRP 值明显升高(CRP=166mg/L[128-244]、155mg/L[102-222]和 207mg/L[135-259])。术后第 7 天 CRP 以 100mg/L 为界值,对术后 IC 的预测效果最佳(AUC=90.1%)。CRP 术后第 5 天,以 90mg/L 为界值,对术后 IC 的预测效果较好(AUC=83.2%)。NLR 值在术后第 3、5、7 天 IC 患者中明显升高。NLR 术后第 5、7 天高于 9.7 和 6.3,预测效果为中等(AUC 分别为 70.8 和 79.6)。
CRS/HIPEC 术后第 3 至 7 天 CRP 水平是术后 IC 的最佳预测指标。术后第 3、5、7 天 CRP 高于 140mg/L、90mg/L 或 100mg/L 时,应怀疑存在术后 IC。